Newsletter | April 2, 2024

04.02.24 -- 2024 And Beyond: The State Of Alzheimer's Disease Research And Drug Development


2024 And Beyond: The State Of Alzheimer's Disease Research And Drug Development

The ongoing advancements in both drug delivery and therapeutic strategies underscore a growing wealth of progress in the battle against Alzheimer's disease.


Lung Cancer Treatment By Inhaled Formulations

Explore the formulation and manufacturing of a topotecan inhaled dry powder and its use in decreasing tumor size in an animal model.

Advancing Precision Medicine With Patient-On-A-Chip

Emulate and Cedars-Sinai Medical Center have partnered to develop a Patient-on-a-Chip program that combines their stem cell expertise and Organs-on-Chips technology to advance precision medicine.

A Lean, Agile Business Model To Deliver High-Quality Oncologic Treatments

No two journeys through the drug pipeline are the same; the ability to leverage a variety of approaches for different products is what sets one lean biotech company apart.

Speed To Market – API Large-Scale Commercial Manufacturing

A pharma company was looking to partner with a CMO with commercial manufacturing capabilities, large-scale assets, multinational sites, and exemplary quality systems/U.S. FDA track record.

End-To-End Cold Chain Management: A Next-Generation Approach

Three experts in cold chain management walk through the advantages of end-to-end platforms for bulk drug substance management.

Streamlined Selection Of In Vivo Predictive Dissolution Media

Explore the design of dissolution media to support biopredictive dissolution testing and a method for selecting practical, physiologically relevant media based upon drug, formulation, and GI fluid properties.


Teva UK & Closed Loop Medicine Announce Strategic Partnership

CinFina Pharma Announces FDA Clearance Of IND Application & First Participants Dosed

Biocytogen Enters Collaboration With ABL Bio To Develop New bsADCs

Researchers Devise New Method To Find Proteins For Targeted Treatment Of Disease

Safer, More Efficient Drug Discovery

High Speed Protein Movies To Aid Drug Design

Bio-Thera Solutions Receives IND Clearance From U.S. FDA For A Phase II Study For BAT8006

Amneal Receives U.S. FDA Approval For Ciprofloxacin And Dexamethasone Otic Suspension

Ubiquigent & Debiopharm Enter Agreement To Support USP1 Inhibitor Programme

EPNextS Group & Frontage Laboratories, Inc. Announce Collaboration To Address "Drug Lag" & "Drug Loss"

Synthekine Announces U.S. FDA Clearance Of IND Application For CD19 CAR-T & Orthogonal IL-2 Combination Therapy, SYNCAR-001 + STK-009


Robust Low Volume RNA-Lipid Nanoparticle Formulation

Analytical Services: Capabilities And Expertise

Particle Control In Biopharmaceuticals